Webinar – Redefining Drug Development with the inGenius Platform

Thanks for joining us – if you would like to re-watch the webinar, the video has been made available below to watch again.

Over the past two decades, the biopharma community has faced significant challenges in advancing exciting and potentially life-saving new targets into the clinic. Throughout this time, Ingenza has partnered with numerous customers and collaborators, developing a suite of innovative platform technologies that are critical to the success of any drug development program. Inspired by groundbreaking advances in genomics, artificial intelligence, and genome editing over the last decade, Ingenza has refined its approach to accelerate and de-risk the path to IND. 

In this webinar, Dr. Rita Cruz, Section Head of Strain Development at Ingenza, will introduce Ingenza’s inGenius™ platform, which plays a pivotal role in speeding up a candidate’s journey to the clinic. The inGenius™ platform includes efficient and proven biomanufacturing hosts and processes that boast a 20-year track record of successful delivery, from novel antibiotic candidates to next-generation vaccines and biologics. By integrating Ingenza’s proprietary gene design algorithm (codABLE™), a comprehensive library of genetic parts, advanced genome editing tools, FACS-assisted optimization of protein expression, and customized fermentation protocols, the inGenius™ platform rapidly demonstrates bioprocess IND readiness to meet future manufacturing productivity, quality and cost requirements. 

This webinar will provide invaluable insights into the past, present, and future of biotech innovations, highlighting how Ingenza’s passion for using biology to transform our world continues to drive the incredible journey of engineering biology. Join us to explore how these revolutionary technologies can accelerate your drug discovery and development efforts, ultimately bringing transformative therapies to patients faster and more efficiently.